Health Roche’s Gazyva Gains FDA Approval for Lupus Nephritis Treatment Roche’s cancer drug, Gazyva, has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of adults with active lupus nephritis,... Editorial20 October, 2025